Endeavor
12 article(s) found
![ASCOHero24_TIL.jpg](https://images2.cmp.optimizely.com/assets/ASCOHero24_TIL.jpg/7340773a22af11efbd407a297940f98e)
Next Generation of TIL Therapy Being Developed for Head and Neck Cancers
![Hoffman Hero image.jpg](https://images1.cmp.optimizely.com/assets/Hoffman+Hero+image.jpg/f9193f8c177811efad0c32ef3d69e9a4)
Moffitt Treats its First Commercial TIL Therapy Patient Since FDA Approval
![TIL.jpg](https://images3.cmp.optimizely.com/assets/TIL.jpg/a2ac3c0c0ef511efad434a94039b6e89)
The Long Journey in Search of a Cure
![](/contentassets/ec8a10f693eb450d930098a7799fe77d/bam-meeting-1440.jpg)
Uniting Engineers, Scientists and Clinicians to Optimize Cancer Research
![](/contentassets/34f9cdea4d154eea8e623e65fdd0861d/t-cell-attacking-cancer-cell.jpg)
New Breakthrough Therapy for Metastatic Melanoma Receives FDA Approval
![](/contentassets/837c320129d345faa4d3f2ab0ed8a93b/t-cells-attacking-tumor-1440.jpg)
Cellular Therapy May Be Viable Option for Advanced Melanoma Patients
![](/contentassets/033232f11a3e4e088094865b47fb23ea/immune-cells-attacking-tumor-1440.jpg)
Moffitt’s Newest Partnership to Advance Cell Therapies for Solid Tumors
![](/contentassets/0be22e99d0c140a8b7f4335f86e975d7/sheri-pummill-1440.jpg)
Once a Fighter, Always a Fighter
![](/contentassets/2d87f9799ad04e91a597fd1a46667a05/head-and-neck-image-1440.jpg)
Harnessing the Immune System to Treat Head and Neck Cancer